Proficio Capital Partners LLC Makes New Investment in Amdocs Limited (NASDAQ:DOX)

Proficio Capital Partners LLC bought a new position in shares of Amdocs Limited (NASDAQ:DOX - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 22,392 shares of the technology company's stock, valued at approximately $1,906,000.

A number of other hedge funds have also recently added to or reduced their stakes in the business. Pzena Investment Management LLC increased its holdings in shares of Amdocs by 12.3% during the 3rd quarter. Pzena Investment Management LLC now owns 6,363,739 shares of the technology company's stock worth $556,700,000 after buying an additional 696,136 shares during the last quarter. Hotchkis & Wiley Capital Management LLC increased its stake in Amdocs by 123.2% during the third quarter. Hotchkis & Wiley Capital Management LLC now owns 759,136 shares of the technology company's stock worth $66,409,000 after acquiring an additional 419,045 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in shares of Amdocs by 1,207.3% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 271,701 shares of the technology company's stock worth $23,768,000 after purchasing an additional 250,918 shares during the period. Geode Capital Management LLC lifted its stake in shares of Amdocs by 10.8% in the 3rd quarter. Geode Capital Management LLC now owns 1,633,733 shares of the technology company's stock valued at $143,498,000 after purchasing an additional 158,843 shares in the last quarter. Finally, Nordea Investment Management AB grew its holdings in shares of Amdocs by 8.3% during the 4th quarter. Nordea Investment Management AB now owns 1,656,055 shares of the technology company's stock worth $141,112,000 after purchasing an additional 127,426 shares during the period. 92.02% of the stock is owned by institutional investors and hedge funds.

Remove Ads

Amdocs Stock Up 0.0 %

Shares of DOX traded up $0.03 during mid-day trading on Monday, reaching $90.49. 956,278 shares of the stock traded hands, compared to its average volume of 665,024. The stock has a fifty day simple moving average of $86.36 and a 200 day simple moving average of $86.97. Amdocs Limited has a 12-month low of $74.41 and a 12-month high of $93.83. The company has a quick ratio of 1.20, a current ratio of 1.16 and a debt-to-equity ratio of 0.22. The firm has a market cap of $10.22 billion, a price-to-earnings ratio of 21.00, a P/E/G ratio of 1.47 and a beta of 0.68.

Amdocs (NASDAQ:DOX - Get Free Report) last posted its quarterly earnings data on Tuesday, February 4th. The technology company reported $1.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.64 by ($0.19). Amdocs had a return on equity of 18.89% and a net margin of 10.19%. Sell-side analysts expect that Amdocs Limited will post 6.21 EPS for the current fiscal year.

Amdocs Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Monday, March 31st will be issued a $0.527 dividend. This is a positive change from Amdocs's previous quarterly dividend of $0.48. This represents a $2.11 annualized dividend and a yield of 2.33%. The ex-dividend date is Monday, March 31st. Amdocs's payout ratio is currently 48.72%.

Analyst Ratings Changes

Several research analysts recently commented on DOX shares. Oppenheimer raised their price target on shares of Amdocs from $98.00 to $105.00 and gave the company an "outperform" rating in a report on Wednesday, November 13th. StockNews.com lowered shares of Amdocs from a "strong-buy" rating to a "buy" rating in a research report on Friday, February 28th. Finally, Barclays reduced their target price on shares of Amdocs from $113.00 to $111.00 and set an "overweight" rating on the stock in a report on Thursday, November 14th. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $101.20.

Amdocs Company Profile

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.